Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Onur Baser

Showing results (21-30 of 156) with videos related to

Pageof 16
Sort By:
Journal of Medical Economics|December 20, 2014
Healthcare utilization and costs of Veterans Health Administration patients with schizophrenia treated with paliperidone palmitate long-acting injection or oral atypical antipsychoticsOnur Baser, Lin Xie, Jacqueline Pesa, et al.
Health & Justice|January 2, 2024
Mental health disparities in young adults with arrest history: a survey-based, cross-sectional analysisOnur Baser, Katarzyna Rodchenko, Yixuan Zeng, et al.
Journal of Medical Economics|July 18, 2013
Real-world rates, predictors, and associated costs of hypoglycemia among patients with type 2 diabetes mellitus treated with insulin glargine: results of a pooled analysis of six retrospective observational studiesLin Xie, Wenhui Wei, Chunshen Pan, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|September 10, 2013
Real-world insulin treatment persistence among patients with type 2 diabetesWenhui Wei, Chunshen Pan, Lin Xie, et al.
Patient Preference and Adherence|October 3, 2013
Real world outcomes of adding rapid-acting insulin versus switching to analog premix insulin among US patients with type 2 diabetes treated with insulin glargineRaymond Miao, Wenhui Wei, Onur Baser, et al.
Journal of Medical Economics|September 7, 2011
Clinical and economic outcomes in patients with type 2 diabetes initiating insulin glargine disposable pen versus exenatide BIDOnur Baser, Wenhui Wei, Erdem Baser, et al.
Journal of Health Economics and Outcomes Research|October 1, 2024
Artificial Intelligence in Identifying Patients With Undiagnosed Nonalcoholic SteatohepatitisOnur Baser, Gabriela Samayoa, Nehir Yapar, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 15, 2013
Real-world outcomes of initiating insulin glargine-based treatment versus premixed analog insulins among US patients with type 2 diabetes failing oral antidiabetic drugsOnur Baser, Krishna Tangirala, Wenhui Wei, et al.
Human Vaccines & Immunotherapeutics|December 19, 2023
Short-term and long-term behavioral effects of vaccination mandatesOnur Baser, Katarzyna Rodchenko, Lu Chen, et al.
American Health & Drug Benefits|August 16, 2014
Anticoagulation Bridging Therapy Patterns in Patients Undergoing Total Hip or Total Knee Replacement in a US Health Plan: Real-World Observations and ImplicationsOnur Baser, Dylan Supina, Nishan Sengupta, et al.
Pageof 16

Showing results (21-30 of 156) with videos related to

Sort By:
Pageof 16
Journal of Medical Economics|December 20, 2014
Healthcare utilization and costs of Veterans Health Administration patients with schizophrenia treated with paliperidone palmitate long-acting injection or oral atypical antipsychoticsOnur Baser, Lin Xie, Jacqueline Pesa, et al.
Health & Justice|January 2, 2024
Mental health disparities in young adults with arrest history: a survey-based, cross-sectional analysisOnur Baser, Katarzyna Rodchenko, Yixuan Zeng, et al.
Journal of Medical Economics|July 18, 2013
Real-world rates, predictors, and associated costs of hypoglycemia among patients with type 2 diabetes mellitus treated with insulin glargine: results of a pooled analysis of six retrospective observational studiesLin Xie, Wenhui Wei, Chunshen Pan, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|September 10, 2013
Real-world insulin treatment persistence among patients with type 2 diabetesWenhui Wei, Chunshen Pan, Lin Xie, et al.
Patient Preference and Adherence|October 3, 2013
Real world outcomes of adding rapid-acting insulin versus switching to analog premix insulin among US patients with type 2 diabetes treated with insulin glargineRaymond Miao, Wenhui Wei, Onur Baser, et al.
Journal of Medical Economics|September 7, 2011
Clinical and economic outcomes in patients with type 2 diabetes initiating insulin glargine disposable pen versus exenatide BIDOnur Baser, Wenhui Wei, Erdem Baser, et al.
Journal of Health Economics and Outcomes Research|October 1, 2024
Artificial Intelligence in Identifying Patients With Undiagnosed Nonalcoholic SteatohepatitisOnur Baser, Gabriela Samayoa, Nehir Yapar, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 15, 2013
Real-world outcomes of initiating insulin glargine-based treatment versus premixed analog insulins among US patients with type 2 diabetes failing oral antidiabetic drugsOnur Baser, Krishna Tangirala, Wenhui Wei, et al.
Human Vaccines & Immunotherapeutics|December 19, 2023
Short-term and long-term behavioral effects of vaccination mandatesOnur Baser, Katarzyna Rodchenko, Lu Chen, et al.
American Health & Drug Benefits|August 16, 2014
Anticoagulation Bridging Therapy Patterns in Patients Undergoing Total Hip or Total Knee Replacement in a US Health Plan: Real-World Observations and ImplicationsOnur Baser, Dylan Supina, Nishan Sengupta, et al.
Pageof 16